Novo Nordisk A/S (NVO) Debt to Equity Ratio

Current and historical debt to equity ratio values for Novo Nordisk A/S (NVO) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $115.617B $15.976B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.